ClinicaliQ Trial Snapshot
- A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234 — Active Not Recruiting • Phase I • NCT07220954.
- Review the linked registry entry for study design, population, endpoints, and operational status.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of AZD6234. This study will take place at one site in Nottingham, United Kingdom, and will enrol 21 healthy men and women aged 18-55 years. Conditions: Healthy Participants Interventions: AZD6234 Formulation 1, AZD6234 Formulation 2 (low concentration), AZD6234 Formulation 2 (high concentration), AZD6234 Formulation 3 Lead Sponsor: AstraZeneca Planned Enrollment: 19 participants